Scarica l'app Stockscreener
38.21
1.95%
-0.76
Dopo l'orario di chiusura:
38.40
0.19
+0.50%
Uniqure Nv Borsa (QURE) Ultime notizie
Uniqure NV (QURE) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Kalehua Capital Management LLC Makes New Investment in uniQure N.V. $QURE - MarketBeat
Orbimed Advisors LLC Has $34.93 Million Holdings in uniQure N.V. $QURE - MarketBeat
Uniqure NV (QURE) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Uniqure NV (QURE) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
QURE Stock Just Shot Up 8%uniQure’s Much-Talked-About Huntington’s Disease Therapy Gets A UK Boost - Stocktwits
uniQure N.V. Revenue Breakdown – FWB:UQ1 - TradingView
QURE|Uniqure NV|Price:38.970|Chg%:-0.460 - TradingKey
uniQure (QURE) to Release Earnings on Wednesday - MarketBeat
uniQure N.V. Revenue Breakdown – BIVA:QURE/N - TradingView
Siren L.L.C. Makes New $16.35 Million Investment in uniQure N.V. $QURE - MarketBeat
Aberdeen Group plc Reduces Holdings in uniQure NV - GuruFocus
Uniqure NV (QURE) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Earnings Preview: UniQure NV to Report Financial Results Pre-market on July 29 - Moomoo
Which Is a Better Investment, Ionis Pharmaceuticals, Inc. or uniQure N.V. Stock? - AAII
Militia Capital Management LLC Purchases New Shares in uniQure N.V. $QURE - MarketBeat
uniQure N.V. to announce Q2 2026 financial results on July 29 - scanx.trade
uniQure to Announce Second Quarter 2026 Financial Results - The Manila Times
uniQure sets July 29 webcast after Q2 financial results - Stock Titan
uniQure N.V. $QURE Shares Sold by Jennison Associates LLC - MarketBeat
JPMorgan Chase & Co. Increases Stake in uniQure NV - GuruFocus
Goldman Sachs Maintains UniQure NV(QURE.US) With Hold Rating, Maintains Target Price $46 - Moomoo
uniQure (QURE) Proxy filing Summary - Quartr
uniQure (NASDAQ:QURE) Shares Pass Above 50 Day Moving AverageTime to Sell? - MarketBeat
Aberdeen Group plc (QURE) discloses 2.85M-share, 4.52% holding in uniQure - Stock Titan
Is QURE Stock Attractive After Its Rally, Rich Valuation, and Hold? - MSN
What Caused uniQure's Dramatic Stock Plunge - Kavout | AI
uniQure NV | 144: Notice of proposed sale of securities pursuant to Rule 144 - Moomoo
uniQure (QURE) Stock Still Looks Expensive Given Its Huntingtons Promise - Yahoo Finance
uniQure Trends to Watch as Gene Therapy Bets Shift Beyond Hemgenix - The Globe and Mail
QURE Stock Outlook Rests on AMT-130, FDA Talks, and Cash Runway - Yahoo Finance
QURE Investors Have Opportunity to Lead uniQure N.V. Securities Fraud Lawsuit - GuruFocus
UniQure (QURE) now trades above golden cross: Time to buy? - MSN
JPMorgan discloses 7% uniQure (QURE) stake of 4,866,211 shares - Stock Titan
uniQure's Huntington's prospects brighten after FDA shift - S&P Global
If You Invested $1,000 in Uniqure (QURE) - Stock Titan
uniQure N.V. (NASDAQ:QURE) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
The Technical Signals Behind (QURE) That Institutions Follow - Stock Traders Daily
QURE Jumps 20% – Analysts Upgrade Stock On Huntington’s Disease Therapy Update, Retail Eyes $150 - Stocktwits
uniQure N.V. $QURE Shares Purchased by Y Intercept Hong Kong Ltd - MarketBeat
UniQure soars as Cantor upgrades on plans to seek gene therapy nod - MSN
uniQure N.V. (QURE) Stock Price | Live Quotes & Charts | NASDAQ - timothysykes.com
uniQure (QURE) Status Update Summary - Quartr
Uniqure Insider Sold Shares Worth $952,051, According to a Recent SEC Filing - Moomoo
uniQure (QURE) CEO sells 21,082 shares after option exercise under 10b5-1 plan - Stock Titan
QURE INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announc - The National Law Review
Price to sales forward of uniQure N.V. – FWB:UQ1 - TradingView
UniQure surges on plans to seek US nod for gene therapy - MSN
QURE Investors Have Opportunity to Lead uniQure N.V. Class Action - The National Law Review
Uniqure Insider Sold Shares Worth $983,030, According to a Recent SEC Filing - Moomoo
uniQure (QURE) CMO sells 30,000 shares and exercises 10,000 stock options - Stock Titan
1.97%
0.83%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):